134
Views
6
CrossRef citations to date
0
Altmetric
Theme: Bladder Cancer - Reviews

Small cell carcinoma of the urinary bladder: a contemporary review with a special focus on bladder-sparing treatments

, &
Pages 1269-1279 | Published online: 10 Jan 2014

References

  • Riaz SP, Luchtenborg M, Coupland VH, Spicer J, Peake MD, Moller H. Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer 75(3), 280–284 (2012).
  • Haider K, Shahid RK, Finch D et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer 107(9), 2262–2269 (2006).
  • Wong YN, Jack RH, Mak V, Henrik M, Davies EA. The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC Cancer 9, 209 (2009).
  • Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. Histopathology 46(1), 57–63 (2005).
  • Cheng L, Pan CX, Yang XJ et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101(5), 957–962 (2004).
  • Koay EJ, Teh BS, Paulino AC, Butler EB. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer 117(23), 5325–5333 (2011).
  • Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 47(4), 724–730 (1981).
  • Church DN, Bahl A. Clinical review – small cell carcinoma of the bladder. Cancer Treat. Rev. 32(8), 588–593 (2006).
  • Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464), 645–648 (1994).
  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100(7), 3983–3988 (2003).
  • Chan KS, Espinosa I, Chao M et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl Acad. Sci. USA 106(33), 14016–14021 (2009).
  • Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6), 823–835 (2005).
  • Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 67(3), 1030–1037 (2007).
  • O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123), 106–110 (2007).
  • Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 432(7015), 396–401 (2004).
  • Tatokoro M, Koga F, Yoshida S et al. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int. J. Cancer 131(4), 987–996 (2012).
  • Bex A, Sonke GS, Pos FJ, Brandsma D, Kerst JM, Horenblas S. Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review. Ann. Oncol. 21(11), 2240–2245 (2010).
  • Siefker-Radtke AO, Dinney CP, Abrahams NA et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J. Urol 172(2), 481–484 (2004).
  • Cheng L, Jones TD, McCarthy RP et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am. J. Pathol. 166(5), 1533–1539 (2005).
  • Gaisa NT, Tilki D, Losen I et al. Insights from a whole cystectomy specimen--association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ. Hum. Pathol. 39(8), 1258–1262 (2008).
  • Martignoni G, Eble JN. Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch. Pathol. Lab. Med. 127(1), e22–e24 (2003).
  • Grignon DJ, Ro JY, Ayala AG et al. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 69(2), 527–536 (1992).
  • Cheng L, Leibovich BC, Cheville JC et al. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 88(4), 844–852 (2000).
  • Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG. Neurofibroma of the urinary bladder. Cancer 86(3), 505–513 (1999).
  • Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103(6), 1172–1178 (2005).
  • Reyes CV, Soneru I. Small cell carcinoma of the urinary bladder with hypercalcemia. Cancer 56(10), 2530–2533 (1985).
  • Eble JN, Sauter G, Epstein JI, Sesterhenn IA Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, France (2004).
  • Thompson S, Cioffi-Lavina M, Chapman-Fredricks J, Gomez-Fernandez C, Fernandez-Castro G, Jorda M. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach. Appl. Immunohistochem. Mol. Morphol. 19(5), 395–399 (2011).
  • Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64(6), 1347–1357 (1989).
  • Leonard C, Huret JL, Gfco. From cytogenetics to cytogenomics of bladder cancers. Bull Cancer 89(2), 166–173 (2002).
  • Terracciano L, Richter J, Tornillo L et al. Chromosomal imbalances in small cell carcinomas of the urinary bladder. J. Pathol. 189(2), 230–235 (1999).
  • Knowles MA. Tumor suppressor loci in bladder cancer. Front. Biosci. 12, 2233–2251 (2007).
  • Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother. Rep. 3, 4(2), 31–42 (1973).
  • Bex A, de Vries R, Pos F, Kerst M, Horenblas S. Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. World J. Urol. 27(1), 101–106 (2009).
  • Bex A, Nieuwenhuijzen JA, Kerst M et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 65(2), 295–299 (2005).
  • Meijer RP, Meinhardt W, van der Poel HG et al. Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. Int. J. Urol. (2012).
  • Quek ML, Nichols PW, Yamzon J et al. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J. Urol. 174(1), 93–96 (2005).
  • Koay EJ, Teh BS, Paulino AC, Butler EB. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int. J. Radiat. Oncol. Biol. Phys. 83(1), 64–70 (2012).
  • Mackey JR, Au HJ, Hugh J, Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J. Urol. 159(5), 1624–1629 (1998).
  • Lynch SP, Shen Y, Kamat A et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the md anderson cancer center. Eur. Urol. 64(2), 307–313 (2013).
  • Sved P, Gomez P, Manoharan M, Civantos F, Soloway MS. Small cell carcinoma of the bladder. BJU Int. 94(1), 12–17 (2004).
  • Siefker-Radtke AO, Kamat AM, Grossman HB et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J. Clin. Oncol. 27(16), 2592–2597 (2009).
  • Koga F, Numao N, Saito K et al. Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients. Urol. Oncol. (2012).
  • Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N. Engl. J. Med. 327(23), 1618–1624 (1992).
  • Coppin CM, Gospodarowicz MK, James K et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The national cancer institute of canada clinical trials group. J. Clin. Oncol. 14(11), 2901–2907 (1996).
  • Bastus R, Caballero JM, Gonzalez G et al. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: results in five cases. Eur. Urol. 35(4), 323–326 (1999).
  • Lohrisch C, Murray N, Pickles T, Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer 86(11), 2346–2352 (1999).
  • June RR, Dougherty DW, Reese CT, Harpster LE, Hoffman SL, Drabick JJ. Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature. Urol. Oncol. 30(2), 192–195 (2012).
  • Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N. Engl. J. Med. 341(7), 476–484 (1999).
  • Mukesh M, Cook N, Hollingdale AE, Ainsworth NL, Russell SG. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int. 103(6), 747–752 (2009).
  • Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology 68(1), 58–64 (2006).
  • Manoharan M, Ayyathurai R, Soloway MS. Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome. BJU Int. 104(9), 1227–1232 (2009).
  • Gilbert SM, Wood DP, Dunn RL et al. Measuring health-related quality of life outcomes in bladder cancer patients using the bladder cancer index (BCI). Cancer 109(9), 1756–1762 (2007).
  • Housset M, Maulard C, Chretien Y et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J. Clin. Oncol. 11(11), 2150–2157 (1993).
  • Kachnic LA, Kaufman DS, Heney NM et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J. Clin. Oncol15(3), 1022–1029 (1997).
  • Rodel C, Grabenbauer GG, Kuhn R et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J. Clin. Oncol. 20(14), 3061–3071 (2002).
  • Koga F, Kihara K. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review. Int. J. Urol. 19(5), 388–401 (2012).
  • Stenzl A, Cowan NC, De Santis M et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur. Urol. 59(6), 1009–1018 (2011).
  • Ismaili N, Heudel PE, Elkarak F et al. Outcome of recurrent and metastatic small cell carcinoma of the bladder. BMC Urol. 9, 4 (2009).
  • Tunio MA, Hashmi A, Qayyum A, Mohsin R, Zaeem A. Whole-pelvis or bladder-only chemoradiation for lymph node-negative invasive bladder cancer: single-institution experience. Int. J. Radiat. Oncol. Biol. Phys. 82(3), e457–e462 (2012).
  • Zietman AL, Grocela J, Zehr E et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58(3), 380–385 (2001).
  • Koga F, Kihara K, Yoshida S et al. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 109(6), 860–866 (2012).
  • Koga F. Editorial Comment from Dr Koga to Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. Int. J. Urol. 20(8), 785–786 (2013).
  • Fung CY, Shipley WU, Young RH et al. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J. Clin. Oncol. 9(9), 1533–1542 (1991).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.